Jefferies Group LLC Mirati Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Sep 21, 2023	BUY	$75.82 - $150.97 $15,163 - $30,194	200 Added 0.79%	25,400 $2.09 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $15,163 - $30,194	200 Added 0.79%	25,400 $2.09 Million
Q3 2021 Sep 21, 2023	SELL	$132.13 - $177.45 $2.85 Million - $3.83 Million	-21,600 Reduced 46.15%	25,200 $4.46 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $2.85 Million - $3.83 Million	-21,600 Reduced 46.15%	25,200 $4.46 Million
Q1 2021 Sep 21, 2023	SELL	$158.92 - $221.61 $1.08 Million - $1.51 Million	-6,800 Reduced 12.69%	46,800 $8.02 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $1.08 Million - $1.51 Million	-6,800 Reduced 12.69%	46,800 $8.02 Million
Q4 2020 Sep 21, 2023	BUY	$162.05 - $240.27 $8.69 Million - $12.9 Million	53,600 New	53,600 $11.8 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $1.35 Million - $1.99 Million	8,300 Added 18.32%	53,600 $11.8 Million
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $4.85 Million - $7.16 Million	42,800 Added 1712.0%	45,300 $7.52 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $2.3 Million - $3.83 Million	-33,000 Reduced 92.96%	2,500 $192,000
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $1.88 Million - $3.43 Million	26,600 Added 298.88%	35,500 $4.58 Million
Q3 2019 Nov 13, 2019	SELL	$77.91 - $109.6 $6.58 Million - $9.26 Million	-84,500 Reduced 90.47%	8,900 $693,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $5.29 Million - $9.31 Million	88,900 Added 1975.56%	93,400 $9.62 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $196,425 - $355,275	4,500 New	4,500 $330,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $2 Million - $2.96 Million	-62,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $2.94 Million - $3.92 Million	62,500 New	62,500 $2.94 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account